Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesina (alogliptin) special drug use surveillance in combination with thiazolidinediones for type 2 diabetes mellitus
jRCT1080222218
- Sponsor
- Takeda
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080222218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222218.